SMAD6 and nasal cavity polyp: Parallels may be drawn between the impact of VPA and TGF-β2 on Smad6 expression and the capacity of trichostatin A, also an HDAC inhibitor, to rescue TGF-β1-suppressed Smad7 in nasal polyp-derived fibroblasts [45].